Company Filing History:
Years Active: 2016-2018
Title: Amy Cagulada: Innovator in Antiviral Compounds
Introduction
Amy Cagulada is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of antiviral research, holding 2 patents that showcase her innovative work. Her dedication to developing effective antiviral agents has positioned her as a key figure in the scientific community.
Latest Patents
Amy's latest patents focus on the synthesis of antiviral compounds. The first patent provides processes for the preparation of a compound of formula I, which is useful as an antiviral agent. This disclosure also includes compounds and processes for the preparation of synthetic intermediates to the compound of formula I. The second patent mirrors the first, emphasizing the importance of her research in creating effective antiviral solutions.
Career Highlights
Amy Cagulada is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company known for its innovative therapies. Her work at Gilead has allowed her to collaborate with some of the brightest minds in the industry, further enhancing her contributions to antiviral research.
Collaborations
Some of her notable coworkers include Johann Chan and Lina Chan. Their collaborative efforts have played a crucial role in advancing the research and development of antiviral compounds.
Conclusion
Amy Cagulada's work in synthesizing antiviral compounds demonstrates her commitment to innovation in the field of medicine. Her patents reflect her expertise and dedication to improving public health through scientific advancements.